{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:44:52Z","timestamp":1792143892287,"version":"4.4.0"},"publisher-location":"New York, NY","reference-count":35,"publisher":"Springer US","isbn-type":[{"value":"9781071655863","type":"print"},{"value":"9781071655870","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2027]]},"DOI":"10.1007\/978-1-0716-5587-0_22","type":"book-chapter","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T08:54:41Z","timestamp":1792140881000},"page":"343-364","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ewing Sarcoma PDX Models"],"prefix":"10.1007","author":[{"given":"Didier","family":"Surdez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Landuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Scotlandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Manara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"issue":"4","key":"22_CR1","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/j.1699-0463.1969.tb04521.x","volume":"77","author":"J Rygaard","year":"1969","unstructured":"Rygaard J (1969) Immunobiology of the mouse mutant \u201cNude\u201d. Preliminary investigations. Acta Pathol Microbiol Scand 77(4):761\u2013762","journal-title":"Acta Pathol Microbiol Scand"},{"issue":"4","key":"22_CR2","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/j.1699-0463.1969.tb04520.x","volume":"77","author":"J Rygaard","year":"1969","unstructured":"Rygaard J, Povlsen CO (1969) Heterotrans-plantation of a human malignant tumour to \u201cNude\u201d mice. Acta Pathol Microbiol Scand 77(4):758\u2013760","journal-title":"Acta Pathol Microbiol Scand"},{"key":"22_CR3","first-page":"343","volume":"74","author":"HH Fiebig","year":"1984","unstructured":"Fiebig HH, Schuchhardt C, Henss H, Fiedler L, Lohr GW (1984) Comparison of tumor response in nude mice and in the patients. Behring Inst Mitt 74:343\u2013352","journal-title":"Behring Inst Mitt"},{"issue":"10","key":"22_CR4","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1054\/bjoc.2001.1796","volume":"84","author":"JI Johnson","year":"2001","unstructured":"Johnson JI, Decker S, Zaharevitz D, Rubinstein LV, Venditti JM, Schepartz S et al (2001) Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials. Br J Cancer 84(10):1424\u20131431","journal-title":"Br J Cancer"},{"issue":"1","key":"22_CR5","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.cell.2016.08.041","volume":"167","author":"A Bruna","year":"2016","unstructured":"Bruna A, Rueda OM, Greenwood W, Batra AS, Callari M, Batra RN et al. (2016) A biobank of breast cancer explants with preserved intra-tumor heterogeneity to screen anticancer compounds. Cell. 167(1):260\u201374 e22","journal-title":"Cell."},{"issue":"8","key":"22_CR6","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1158\/1535-7163.MCT-11-0233","volume":"10","author":"M Hidalgo","year":"2011","unstructured":"Hidalgo M, Bruckheimer E, Rajeshkumar NV, Garrido-Laguna I, De Oliveira E, Rubio-Viqueira B et al (2011) A pilot clinical study of treatment guided by personalized tumorgrafts in patients with advanced cancer. Mol Cancer Ther 10(8):1311\u20131316","journal-title":"Mol Cancer Ther"},{"issue":"10","key":"22_CR7","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1093\/annonc\/mdx416","volume":"28","author":"E Izumchenko","year":"2017","unstructured":"Izumchenko E, Paz K, Ciznadija D, Sloma I, Katz A, Vasquez-Dunddel D et al (2017) Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors. Ann Oncol 28(10):2595\u2013605.","journal-title":"Ann Oncol"},{"issue":"1","key":"22_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-48634-y","volume":"9","author":"P Nanni","year":"2019","unstructured":"Nanni P, Landuzzi L, Manara MC, Righi A, Nicoletti G, Cristalli C et al (2019) Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations. Sci Rep 9(1):12174","journal-title":"Sci Rep"},{"issue":"5","key":"22_CR9","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1158\/2159-8290.CD-16-1154","volume":"7","author":"C Pauli","year":"2017","unstructured":"Pauli C, Hopkins BD, Prandi D, Shaw R, Fedrizzi T, Sboner A et al (2017) Personalized in vitro and in vivo cancer models to guide precision medicine. Cancer Discov 7(5):462\u2013477","journal-title":"Cancer Discov"},{"issue":"7670","key":"22_CR10","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature23647","volume":"549","author":"E Stewart","year":"2017","unstructured":"Stewart E, Federico SM, Chen X, Shelat AA, Bradley C, Gordon B et al (2017) Orthotopic patient-derived xenografts of paediatric solid tumours. Nature 549(7670):96\u2013100","journal-title":"Nature"},{"issue":"9","key":"22_CR11","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1158\/2159-8290.CD-14-0001","volume":"4","author":"M Hidalgo","year":"2014","unstructured":"Hidalgo M, Amant F, Biankin AV, Budinska E, Byrne AT, Caldas C et al (2014) Patient-derived xenograft models: an emerging platform for translational cancer research. Cancer Discov 4(9):998\u20131013","journal-title":"Cancer Discov"},{"issue":"7_Supplement","key":"22_CR12","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.1158\/1538-7445.AM2023-3571","volume":"83","author":"A Federico","year":"2023","unstructured":"Federico A, Gopisetty A, Surdez D, Iddir Y, Saint-Charles A, Wierzbinska J et al (2023) Abstract 3571: The ITCC-P4 sustainable platform of fully characterized PDXs supports the preclinical proof-of-concept drug testing of high-risk pediatric tumor models. Cancer Res 83(7_Supplement):3571","journal-title":"Cancer Res"},{"issue":"7","key":"22_CR13","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/pbc.21078","volume":"49","author":"PJ Houghton","year":"2007","unstructured":"Houghton PJ, Morton CL, Tucker C, Payne D, Favours E, Cole C et al (2007) The pediatric preclinical testing program: description of models and early testing results. Pediatr Blood Cancer 49(7):928\u2013940","journal-title":"Pediatr Blood Cancer"},{"key":"22_CR14","doi-asserted-by":"crossref","unstructured":"Dela Cruz FS, Stewart EA, Surdez D, Daley JD, Soragni A, Tomazou EM, et al (2026) Advancing preclinical biology for Ewing sarcoma: an international effort. Mol Cancer Ther 25(1):48\u201370","DOI":"10.1158\/1535-7163.MCT-25-0428"},{"issue":"7","key":"22_CR15","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1093\/annonc\/mdw041","volume":"27","author":"MF Sanmamed","year":"2016","unstructured":"Sanmamed MF, Chester C, Melero I, Kohrt H (2016) Defining the optimal murine models to investigate immune checkpoint blockers and their combination with other immunotherapies. Ann Oncol 27(7):1190\u20131198","journal-title":"Ann Oncol"},{"issue":"7","key":"22_CR16","first-page":"563","volume":"4","author":"S Rong","year":"1993","unstructured":"Rong S, Oskarsson M, Faletto D, Tsarfaty I, Resau JH, Nakamura T et al (1993) Tumorigenesis induced by coexpression of human hepatocyte growth factor and the human met protooncogene leads to high levels of expression of the ligand and receptor. Cell Growth Differ 4(7):563\u2013569","journal-title":"Cell Growth Differ"},{"issue":"1","key":"22_CR17","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/sj.onc.1208181","volume":"24","author":"YW Zhang","year":"2005","unstructured":"Zhang YW, Su Y, Lanning N, Gustafson M, Shinomiya N, Zhao P et al. (2005) Enhanced growth of human met-expressing xenografts in a new strain of immunocompromised mice transgenic for human hepatocyte growth factor\/scatter factor. Oncogene 24(1):101\u2013106","journal-title":"Oncogene"},{"issue":"1","key":"22_CR18","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41392-023-01419-2","volume":"8","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wu W, Cai C, Zhang H, Shen H, Han Y (2023) Patient-derived xenograft models in cancer therapy: technologies and applications. Signal Transduct Target Ther 8(1):160","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"22_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-62673-2","volume":"16","author":"F Ringnalda","year":"2025","unstructured":"Ringnalda F, van Son GJF, Verweij LHG, Kim SY, Amo-Addae V, Flucke UE et al (2025) Small round cell sarcoma tumoroid biobank reveals CIC::DUX4 sarcoma vulnerability to MCL-1 inhibition. Nat Commun 16(1):7689","journal-title":"Nat Commun"},{"issue":"1","key":"22_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-018-1487-6","volume":"16","author":"W Lu","year":"2018","unstructured":"Lu W, Chao T, Ruiqi C, Juan S, Zhihong L (2018) Patient-derived xenograft models in musculoskeletal malignancies. J Transl Med 16(1):107","journal-title":"J Transl Med"},{"issue":"1","key":"22_CR21","doi-asserted-by":"publisher","first-page":"30","DOI":"10.30802\/AALAS-JAALAS-18-000010","volume":"58","author":"RL Erickson","year":"2019","unstructured":"Erickson RL, Blevins CE, Souza Dyer C, Marx JO (2019) Alfaxalone-xylazine anesthesia in laboratory mice (Mus musculus). J Am Assoc Lab Anim Sci 58(1):30\u201339","journal-title":"J Am Assoc Lab Anim Sci"},{"issue":"7","key":"22_CR22","doi-asserted-by":"publisher","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M et al (2020) The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol 18(7):e3000410","journal-title":"PLoS Biol"},{"issue":"7","key":"22_CR23","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/hmg\/10.7.657","volume":"10","author":"OP Kallioniemi","year":"2001","unstructured":"Kallioniemi OP, Wagner U, Kononen J, Sauter G (2001) Tissue microarray technology for high-throughput molecular profiling of cancer. Hum Mol Genet 10(7):657\u2013662","journal-title":"Hum Mol Genet"},{"key":"22_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/978-1-62703-287-2_2","volume":"980","author":"H Remotti","year":"2013","unstructured":"Remotti H (2013) Tissue microarrays: construction and use. Methods Mol Biol 980:13\u201328","journal-title":"Methods Mol Biol"},{"key":"22_CR25","unstructured":"Antonescu CR, Board WHOCoTE, World Health O, International Agency for Research on C (2020) Soft tissue and bone tumours. 5th edition ed. International Agency for Research on Cancer, Lyon. p 607"},{"issue":"1","key":"22_CR26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/00000478-198004010-00003","volume":"4","author":"AG Nascimento","year":"1980","unstructured":"Nascimento AG, Unii KK, Pritchard DJ, Cooper KL, Dahlin DC (1980) A clinicopathologic study of 20 cases of large-cell (atypical) Ewing\u2019s sarcoma of bone. Am J Surg Pathol 4(1):29\u201336","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"22_CR27","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.18632\/oncotarget.20098","volume":"9","author":"MC Baldauf","year":"2018","unstructured":"Baldauf MC, Orth MF, Dallmayer M, Marchetto A, Gerke JS, Rubio RA et al (2018) Robust diagnosis of Ewing sarcoma by immunohistochemical detection of super-enhancer-driven EWSR1-ETS targets. Oncotarget 9(2):1587\u2013601.","journal-title":"Oncotarget"},{"issue":"5","key":"22_CR28","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00428-014-1627-1","volume":"465","author":"R Shibuya","year":"2014","unstructured":"Shibuya R, Matsuyama A, Nakamoto M, Shiba E, Kasai T, Hisaoka M (2014) The combination of CD99 and NKX2.2, a transcriptional target of EWSR1-FLI1, is highly specific for the diagnosis of Ewing sarcoma. Virch Arch 465(5):599\u2013605","journal-title":"Virch Arch"},{"issue":"9","key":"22_CR29","doi-asserted-by":"publisher","first-page":"e0160587","DOI":"10.1371\/journal.pone.0160587","volume":"11","author":"VE Schneeberger","year":"2016","unstructured":"Schneeberger VE, Allaj V, Gardner EE, Poirier JT, Rudin CM (2016) Quantitation of murine stroma and selective purification of the human tumor component of patient-derived xenografts for genomic analysis. PLoS ONE 11(9):e0160587","journal-title":"PLoS ONE"},{"issue":"3","key":"22_CR30","first-page":"227","volume":"61","author":"P Huang","year":"2011","unstructured":"Huang P, Westmoreland SV, Jain RK, Fukumura D (2011) Spontaneous nonthymic tumors in SCID mice. Comp Med 61(3):227\u2013234","journal-title":"Comp Med"},{"issue":"39","key":"22_CR31","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.18632\/oncotarget.27001","volume":"10","author":"AM Moyer","year":"2019","unstructured":"Moyer AM, Yu J, Sinnwell JP, Dockter TJ, Suman VJ, Weinshilboum RM et al (2019) Spontaneous murine tumors in the development of patient-derived xenografts: a potential pitfall. Oncotarget 10(39):3924\u201330.","journal-title":"Oncotarget"},{"issue":"11","key":"22_CR32","doi-asserted-by":"publisher","first-page":"e104227","DOI":"10.1371\/journal.pone.0104227","volume":"9","author":"L de Plater","year":"2014","unstructured":"de Plater L, Vincent-Salomon A, Berger F, Nicolas A, Vacher S, Gravier E et al (2014) Predictive gene signature of response to the anti-TweakR mAb PDL192 in patient-derived breast cancer xenografts. PLoS ONE 9(11):e104227","journal-title":"PLoS ONE"},{"issue":"6","key":"22_CR33","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/labinvest.3780299","volume":"81","author":"M Peter","year":"2001","unstructured":"Peter M, Gilbert E, Delattre O (2001) A multiplex real-time PCR assay for the detection of gene fusions observed in solid tumors. Lab Invest 81(6):905\u2013912","journal-title":"Lab Invest"},{"issue":"11","key":"22_CR34","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1158\/2159-8290.CD-14-0622","volume":"4","author":"F Tirode","year":"2014","unstructured":"Tirode F, Surdez D, Ma X, Parker M, Le Deley MC, Bahrami A et al (2014) Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations. Cancer Discov 4(11):1342\u20131353","journal-title":"Cancer Discov"},{"issue":"21","key":"22_CR35","doi-asserted-by":"publisher","first-page":"e62","DOI":"10.1158\/0008-5472.CAN-17-0582","volume":"77","author":"TF Meehan","year":"2017","unstructured":"Meehan TF, Conte N, Goldstein T, Inghirami G, Murakami MA, Brabetz S et al (2017) PDX-MI: minimal information for patient-derived tumor xenograft models. Cancer Res 77(21):e62\u2013e66","journal-title":"Cancer Res"}],"container-title":["Methods in Molecular Biology","Ewing Sarcoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5587-0_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T08:54:43Z","timestamp":1792140883000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/chapter\/10.1007\/978-1-0716-5587-0_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"ISBN":["9781071655863","9781071655870"],"references-count":35,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5587-0_22","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"16 October 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}